Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187057 · ClinicalTrials.gov registry record · NA
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00187057 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 6 participants.
The verdict
NCT00187057, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a pilot/feasibility study designed to investigate the feasibility of treating children with Ataxia-Telangiectasia (A-T) and cancer with regimens nearly as intense as non-A-T patients with cancer would receive.
Interventions
- PROCEDURE chemotherapy, intrathecal chemotherapy, steroid therapy
- DRUG vinblastine, vincristine, prednisone, daunorubicin
- DRUG doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
- DRUG etoposide, cytarabine, mercaptopurine
- DRUG dexamethasone, procarbazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187057
The ClinicalTrials.gov registry entry for NCT00187057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which chemotherapy, intrathecal chemotherapy, steroid therapy is the first listed.
NCT00187057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187057 about?
NCT00187057 is a clinical study titled "Study for Treatment of Cancer in Children With Ataxia-telangiectasia". This is a pilot/feasibility study designed to investigate the feasibility of treating children with Ataxia-Telangiectasia (A-T) and cancer with regimens nearly as intense as non-A-T patients with cancer would receive.
What is the current status of trial NCT00187057?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2002-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00187057?
The interventions under investigation include: chemotherapy, intrathecal chemotherapy, steroid therapy (PROCEDURE), vinblastine, vincristine, prednisone, daunorubicin (DRUG), doxorubicin, methotrexate, cyclophosphamide, L-asparaginase (DRUG), etoposide, cytarabine, mercaptopurine (DRUG), dexamethasone, procarbazine (DRUG).
Who is sponsoring clinical trial NCT00187057?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.